HeartBeam Strengthens Cardiac Care Innovation with New Patents
HeartBeam Inc. secures new patents for its 3D ECG device, enhancing remote cardiac diagnostics with innovative technology under FDA review.
This news is significant as it highlights HeartBeam's advancements in remote cardiac diagnostics, offering patients and physicians a portable, efficient solution for monitoring heart health outside traditional medical settings. The integration of AI and the expansion of their patent portfolio could revolutionize how cardiac conditions are diagnosed and managed, making timely and accurate heart care more accessible to people everywhere.
